Furthermore, overexpression of SphK in NIH3T3 cells revealed an enhanced cell cycle transition [35], and expression of SphK was considered a marker of poor prognosis in breast cancer [36], and correlated with malignancy in thyroid cancer [30]. The gene discussed is SPHK1; the disease is breast carcinoma.